|
Market Research Report
CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology Industry
| Published by |
Frost & Sullivan |
| Published |
July, 2009 |
Product code |
96216 |
| Content info |
54 Pages |
| Price |
|
|
CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology Industry published by Frost & Sullivan in July, 2009. This report consists of 54 Pages and the price starts from US $ 6000.
Abstract
This research service presents the CEO 360 Degree Perspective for the global
pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of
research from more than 50 Pharmaceutical research services generated by Frost
& Sullivan, customer research findings based on approximately 1,000 end-user
interviews approximately 50,000 hours of analyst research, in the last 2
years. Global healthcare analysts from Frost & Sullivan have contributed their
market knowledge to cover the most important issues that are relevant in the
healthcare industry today. The report also includes research findings from
econometric, advanced technology and several other business divisions of Frost
& Sullivan.
Table of Contents
1. PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRY
Introduction
- Title
- Disclaimer
- Certification
- Research Overview and Background
- 360 Degree Perspective and the Complex Business Universe
- Table of Contents
Global Perspective
- Global Perspective
- Shifting Global Clinical Trial Dynamics
- Shift In Growth From Mature Markets To Emerging Markets
Integrated Industry Perspective
- Integrated Industry Perspective
- Adaptation To Changing Business Models
- Consolidation of Pfizer and Wyeth
- Convergence of Healthcare Allows for Personalization
- Move from Transactional to Strategic Outsourcing Partnerships Encourages
Standardization of LIMS
Technology Perspective
- Technology Perspective
- Oral Oncology Drugs Increasing in Importance
- Advances in Genomics Promotes Healthcare Paradigm Shift
- Effective Screening Methods to Select the Most Promising Drug Candidates
- Growth of Vaccines Market Boosting Technology Innovation
- Gene Therapy Driving Market
Economic Perspective
- Economic Perspective
- Venture Capital Investment in U.S. Biotechnology has Decreased to Levels
Not Seen Since 2002
- Decreasing Number of Biotech IPO' s due to Economic Downturn
- Restructuring
- Continued Healthcare Spending Growth
Competitive Perspective
- Competitive Perspective
- Companies Transforming to Comprehensive Solution Providers
- Repositioning of Platform Technology Providers in Response to Biomarker
Discovery and Diagnostics Development
- Expansion of Biosimilars Alters Industry Landscape
Customer Perspective
- Customer Perspective
- Power Patient Generation
- eDetailing To Assume More Significance
- Medical Tourism - Emerging Hot Spots
Best Practices Perspective
- Best Practices Perspective
- Green Chemistry Initiatives
- Focus on Diseases with High Unmet Needs and Special Designations
- Lower Cost Drugs for Developing Countries
- Employing Hybrid Business Models
About Frost & Sullivan
|
